| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.055 | 0.3 |